Back to search
FDAFDA · Food and drugs·Recall number Z-0382-2022

Bartels Legionella Urinary Antigen- an adjunct to culture for the presumptive diagnosis of past or current Legionnaire's Disease by qualitative detection of Legionella Pneumophila seragroup 1 antigen in human urine. Product Code: B1029-440

Published December 22, 2021 · Recall initiated: October 11, 2021

Summary

FDA records medical device Class II recall Z-0382-2022, published December 22, 2021 and initiated October 11, 2021. Recalling firm: Clark Laboratories, Inc.; Status: Terminated; Reported quantity: 53 units; Lot: Lot # 056 Expiration Date: 2022-11-28 UDI: 05391516744065. Class II means possible temporary or medically reversible effects, or a remote probability of serious health consequences.

Status when published: Terminated — openFDA updates weekly, so this field may not reflect the current status. Always confirm with the official notice.

What's the hazard

Contamination of the conjugate may cause a pipetting issue which then could lead to an invalid assay

What to do

Voluntary: Firm initiated · Letter

Get an email when a new FDA recall like this is published

Free. We only write when there's a new recall that matches. Unsubscribe in one click.

Recall details

Manufacturer
Clark Laboratories, Inc.
Distributor
OH, UT
Lot
Lot # 056 Expiration Date: 2022-11-28 UDI: 05391516744065
Risk classification
Class II
Area (FDA)
device
Country
United States

Related recalls

Questions about this recall

Was Bartels Legionella Urinary Antigen- an adjunct to culture for the presumptive diagnosis of past or current Legionnaire's Disease by qualitative detection of Legionella Pneumophila seragroup 1 antigen in human urine. Product Code: B1029-440 recalled?

Yes. FDA published recall Z-0382-2022 on December 22, 2021. Reported hazard: Contamination of the conjugate may cause a pipetting issue which then could lead to an invalid assay

What should I do if I have this product?

Voluntary: Firm initiated · Letter